{"disease":{"id":"ulcerative-colitis-uc","name":"ulcerative colitis uc"},"drugs":{"marketed":[{"drug_id":"chembl-chembl3358920","indication_name":"moderately to severely active ulcerative colitis (UC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Velsipity","generic_name":"ETRASIMOD","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":49,"revenue":null,"mechanism":"Velsipity works by binding to and modulating the activity of certain immune cells in the body."},{"drug_id":"tofacitinib-xeljanz","indication_name":"Ulcerative Colitis (UC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tofacitinib (Xeljanz)","generic_name":"tofacitinib-xeljanz","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"JAK1 and JAK3","drug_class":"Janus Kinase Inhibitor","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03944447","title":"Outcomes Mandate National Integration With Cannabis as Medicine","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"OMNI Medical Services, LLC","has_results":false},{"nct_id":"NCT03456206","title":"Chronic Inflammatory Disease, Lifestyle and Risk of Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":57053,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT07261826","title":"Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Chen QiYi","has_results":false},{"nct_id":"NCT07166588","title":"Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03398148","title":"A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":1558,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT02819635","title":"A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":1302,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT05578313","title":"Inflammatory Bowel Diseases (IBD) Cannabis Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Eli Sprecher, MD","has_results":false},{"nct_id":"NCT04998084","title":"Advanced Therapy Registry of IBD Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Tel-Aviv Sourasky Medical Center","has_results":false},{"nct_id":"NCT04912999","title":"Inflammatory Bowel Diseases Remission Registry","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Tel-Aviv Sourasky Medical Center","has_results":false},{"nct_id":"NCT02065622","title":"Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":952,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT07398586","title":"The Association Between Interleukin-7 Receptor Gene Polymorphism and the Risk of Ulcerative Colitis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":898,"lead_sponsor_name":"Second Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT07263464","title":"The Association Between TNFSF4 Polymorphism and CD","phase":"","overall_status":"COMPLETED","enrollment_count":818,"lead_sponsor_name":"Second Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT06646757","title":"Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome Disability","phase":"NA","overall_status":"COMPLETED","enrollment_count":803,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT07459686","title":"An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":553,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT03653026","title":"A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":522,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT04014413","title":"Safety and Efficacy of Fecal Microbiota Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06962020","title":"Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Xijing Hospital of Digestive Diseases","has_results":false},{"nct_id":"NCT07240168","title":"CurQD as Add-On Therapy in Vedolizumab-Treated Ulcerative Colitis Patients: Retrospective Cohort Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Evinature Ltd.","has_results":false},{"nct_id":"NCT07436910","title":"Health-Related Quality of Life Among Patients With Inflammatory Bowel Disease","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":385,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT06095596","title":"Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":334,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT06709209","title":"AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University College Cork","has_results":false},{"nct_id":"NCT05447572","title":"FIT Combining FC for Predicting MH and Histology Remission in UC","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Shandong University","has_results":false},{"nct_id":"NCT07507513","title":"The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":288,"lead_sponsor_name":"Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.","has_results":false},{"nct_id":"NCT02738125","title":"Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":265,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT07402135","title":"Fecal Noninvasive Biomarkers Oriented Control Versus Usual Care Strategy in Ulcerative Colitis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":240,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT03758443","title":"Efficacy & Safety of TD-1473 in Ulcerative Colitis","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":239,"lead_sponsor_name":"Theravance Biopharma","has_results":true},{"nct_id":"NCT06895252","title":"A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Ulcerative Colitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"All India Institute of Medical Sciences","has_results":false},{"nct_id":"NCT07245394","title":"Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"TIDHI Innovation Inc.","has_results":false},{"nct_id":"NCT07237516","title":"Zymfentra (Infliximab-dyyb) REal World Cohort STudy","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT04672161","title":"Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT07188727","title":"Comparative Outcomes of Ulcerative Colitis Patients With Mayo Endoscopic Score 1 and Histologic Activity Versus Mayo Endoscopic Score 2","phase":"","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT06860009","title":"Psychological Intervention for Fatigue in Inflammatory Bowel Diseases","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":155,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT07273760","title":"VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"AryoGen Pharmed Co.","has_results":false},{"nct_id":"NCT07059130","title":"Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Rubix LS","has_results":false},{"nct_id":"NCT07442045","title":"Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT07271069","title":"Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07335055","title":"A Study for HSK47388 in Participants With Ulcerative Colitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT05377580","title":"A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Innovent Biologics (Suzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT07535489","title":"Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":144,"lead_sponsor_name":"Nanjing Immunophage Biotech Co., Ltd","has_results":false},{"nct_id":"NCT07113522","title":"A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":140,"lead_sponsor_name":"Mirador Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07289672","title":"Food Limitations In Crohn's Disease and Ulcerative coliTis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT03747068","title":"The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease.","phase":"","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"HaEmek Medical Center, Israel","has_results":false},{"nct_id":"NCT07123350","title":"Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT06954311","title":"Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Medical University Innsbruck","has_results":false},{"nct_id":"NCT06722456","title":"Assessment of Non-invasive Tools for Detecting Active Inflammatory Bowel Disease","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":120,"lead_sponsor_name":"Jean-François Beaulieu","has_results":false},{"nct_id":"NCT07224113","title":"Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Connecticut Children's Medical Center","has_results":false},{"nct_id":"NCT03801928","title":"Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease","phase":"","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03223012","title":"Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service","phase":"","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT07303686","title":"De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":115,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}